|
FDA approves first biosimilar for the treatment of cancer
|
14 September 2017 |
|
FDA approves Mylotarg for treatment of acute myeloid leukemia
|
01 September 2017 |
|
FDA approval brings first gene therapy to the United States
|
30 August 2017 |
|
FDA approves first U.S. treatment for Chagas disease
|
30 August 2017 |
|
FDA approves new treatment for adults with relapsed or refractory acute lymphoblastic leukemia
|
17 August 2017 |
|
FDA to expand public education campaign to focus on prevention of youth e-cigarette use
|
08 August 2017 |
|
FDA approves treatment for chronic graft versus host disease
|
02 August 2017 |
|
FDA announces comprehensive regulatory plan to shift trajectory of tobacco-related disease, death
|
28 July 2017 |
|
FDA approves Vosevi for Hepatitis C
|
19 July 2017 |
|
FDA tackles drug competition to improve patient access
|
27 June 2017 |
|
Statement from FDA Commissioner Scott Gottlieb, M.D., on the importance of the Drug Quality and Security Act and overseeing the safety of compounded drugs
|
26 June 2017 |
|
FDA approves first generic Strattera for the treatment of ADHD
|
31 May 2017 |
|
FDA approves first cancer treatment for any solid tumor with a specific genetic feature
|
23 May 2017 |
|
FDA approves drug to treat ALS
|
05 May 2017 |
|
FDA approves first treatment for a form of Batten disease
|
27 April 2017 |
|
FDA takes action against 14 companies for selling illegal cancer treatments
|
25 April 2017 |
|
FDA approves first drug to treat tardive dyskinesia
|
12 April 2017 |
|
FDA allows marketing of first direct-to-consumer tests that provide genetic risk information for certain conditions
|
06 April 2017 |
|
FDA approves new eczema drug Dupixent
|
28 March 2017 |
|
FDA approves first treatment for rare form of skin cancer
|
24 March 2017 |